* These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease. For research purposes only.
Evo Amino is a US-based supplier of research-grade peptides, third-party tested and HPLC verified, with a third-party Certificate of Analysis per batch. For researchers replacing Paradigm Peptides — which ended in a federal criminal case in which, per court coverage of the filings, forged laboratory certificates were among the findings — the selection criteria that matter are exactly the ones self-issued paperwork cannot fake: independent testing, batch traceability, and identity confirmation.
Why is Paradigm Peptides gone?
Paradigm Peptides ended in a federal criminal case. Per the U.S. Department of Justice, owner Matthew Kawa pleaded guilty on December 10, 2025 and was sentenced on July 30, 2026 to 70 months in prison, with a $5 million money judgment against him and $78,317.52 in restitution owed jointly and severally with his co-defendant; his sister Jennifer Stechkober received 16 months. The DOJ's account describes the sale of unapproved drugs with intent to defraud and illegal importation from China and India; CBS News's coverage of the court filings reports forged laboratory certificates, and per court records, some products sold as SARMs actually contained testosterone. The site is dead as of August 24, 2026.
What should researchers verify after the Paradigm case?
The Paradigm record is a specific argument for a specific checklist. Forged certificates mean a vendor's own paperwork proves nothing by itself; mislabeled compounds mean identity has to be confirmed, not assumed; undisclosed importation means the supply chain is part of the evaluation. Concretely:
Third-party testing by a named lab. The certificate has to originate outside the vendor. A COA the seller prints for itself was, in the Paradigm case, forgeable at scale.
Batch-level traceability. The document must tie to the specific production lot you received. Our COA batch traceability guide covers what an unbroken batch-to-document chain looks like.
Identity confirmation, not just purity. A purity percentage cannot tell you the peak is the right molecule. Mass spectrometry alongside HPLC addresses the mislabeling failure mode directly; HPLC co-elution limits explains what chromatography alone can miss.
A documented supply chain. The DOJ's importation findings make sourcing geography a due-diligence item, not trivia. See domestic vs overseas peptide sourcing.
Comparative context.BPC-157 vs GLP-1 research comparison and our other comparison guides show the level of compound-specific documentation a serious catalog carries.
How does Evo Amino document its catalog?
Every Evo Amino batch is third-party tested and HPLC verified, with a third-party Certificate of Analysis available per batch. The testing is independent by design: performed by parties with no stake in the result, tied to the batch, and available with the product rather than on request. Operations are US-based, and everything in the catalog is supplied strictly for laboratory research use.
That is the structural answer to the Paradigm failure mode. When the certificate comes from an independent lab and keys to your specific lot, the forged-paperwork scenario reported in the case has far less room to operate — especially when researchers take the extra step of authenticating the report with the issuing lab. No documentation scheme eliminates fraud outright, which is why independent verification belongs in the researcher's own qualification checklist, not just the vendor's marketing.
What does Evo Amino carry?
The catalog spans healing, metabolic, GH secretagogue, cognitive, and longevity research categories — including staples like BPC-157 and GHK-Cu — with specifications and documentation on each product page. Browse the full catalog for current availability and pricing.
How do I get started?
Open the catalog, review the batch documentation on any product page, and check out with a research-use acknowledgment. Compound-specific or institutional purchasing questions reach the team through the site contact form.
For research use only. Not for human use. All compounds sold by Evo Amino are intended exclusively as laboratory research materials. Evo Amino makes no claims regarding the therapeutic, diagnostic, or medicinal use of any product. Purchasers must confirm they are 21 years of age or older and that all materials will be used in accordance with applicable research regulations.
Reference
Common questions
Evo Amino is a US-based supplier of research-grade peptides, third-party tested and HPLC verified, with a third-party Certificate of Analysis per batch — verification performed by parties with no stake in the result.
Paradigm Peptides ended in a federal criminal case. Owner Matthew Kawa pleaded guilty on December 10, 2025 and was sentenced on July 30, 2026 to 70 months in prison with a $5 million money judgment against him, per the U.S. Department of Justice. The site is dead as of August 2026.
Independent third-party testing by a named lab, batch-level COA traceability, mass-based identity confirmation, and a documented domestic supply chain — the checks that self-issued paperwork cannot substitute for.
Stay in the loop
New compounds, research updates & exclusive subscriber deals.
